Matches in Nanopublications for { ?s ?p ""The use of Desflurane, USP, Liquid for Inhalation is contraindicated in the following conditions: Known or suspected genetic susceptibility to malignant hyperthermia. Patients in whom general anesthesia is contraindicated. Induction of anesthesia in pediatric patients. Patients with known sensitivity to Desflurane, USP, Liquid for Inhalation or to other halogenated agents [See Warnings and Precautions (5.6) ] Patients with a history of moderate to severe hepatic dysfunction following anesthesia with Desflurane, USP, Liquid for Inhalation or other halogenated agents and not otherwise explained [See Warnings and Precautions (5.6) ] Patients with known or suspected genetic susceptibility to malignant hyperthermia ( 4 Patients in whom general anesthesia is contraindicated ( 4 Induction of anesthesia in pediatric patients ( 4 Patients with known sensitivity to halogenated agents ( 4 Patients with a history of moderate to severe hepatic dysfunction following anesthesia with halogenated agents and not otherwise explained. ( 4"" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""The use of Desflurane, USP, Liquid for Inhalation is contraindicated in the following conditions: Known or suspected genetic susceptibility to malignant hyperthermia. Patients in whom general anesthesia is contraindicated. Induction of anesthesia in pediatric patients. Patients with known sensitivity to Desflurane, USP, Liquid for Inhalation or to other halogenated agents [See Warnings and Precautions (5.6) ] Patients with a history of moderate to severe hepatic dysfunction following anesthesia with Desflurane, USP, Liquid for Inhalation or other halogenated agents and not otherwise explained [See Warnings and Precautions (5.6) ] Patients with known or suspected genetic susceptibility to malignant hyperthermia ( 4 Patients in whom general anesthesia is contraindicated ( 4 Induction of anesthesia in pediatric patients ( 4 Patients with known sensitivity to halogenated agents ( 4 Patients with a history of moderate to severe hepatic dysfunction following anesthesia with halogenated agents and not otherwise explained. ( 4"" assertion.